This is a StreetInsider.com Premium Only Page

(VRCA) – Hot FDA News

Jul 24, 2023 07:02 AM Verrica Pharmaceuticals (VRCA) Confirms FDA Approval of YCANTH for the Treatment of Molluscum Contagiosum, Enters into Non-Binding Term Sheet for up to $125 Million Debt Financing

May 25, 2022 05:49 AM Verrica Pharmaceuticals (VRCA) Receives CRL for VP-102 as a Direct Result of Deficiencies at General Reinspection of Sterling Pharmaceuticals Services

Sep 20, 2021 04:06 PM

May 28, 2021 07:30 AM

Jul 14, 2020 07:03 AM

Jun 26, 2019 04:03 PM